🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 20 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 26/04/2004 | 87,70 | 90,54 | 87,02 | 88,93 | +2,02% | 4,01% | 543.364 |
| 23/04/2004 | 87,81 | 88,52 | 86,84 | 87,17 | -0,26% | 1,92% | 245.820 |
| 22/04/2004 | 84,18 | 87,92 | 82,83 | 87,40 | +4,24% | 6,05% | 409.860 |
| 21/04/2004 | 82,08 | 84,78 | 81,86 | 83,84 | +2,66% | 3,56% | 418.303 |
| 20/04/2004 | 83,51 | 85,34 | 81,56 | 81,67 | -1,80% | 4,53% | 546.409 |
| 19/04/2004 | 81,71 | 84,44 | 80,29 | 83,17 | +2,35% | 5,08% | 342.027 |
| 16/04/2004 | 79,95 | 82,83 | 79,13 | 81,26 | +1,69% | 4,63% | 432.062 |
| 15/04/2004 | 79,16 | 81,37 | 78,57 | 79,91 | +0,90% | 3,55% | 508.605 |
| 14/04/2004 | 78,34 | 80,14 | 77,29 | 79,20 | +0,09% | 3,63% | 351.671 |
| 13/04/2004 | 79,88 | 80,51 | 77,33 | 79,13 | -0,38% | 3,98% | 298.345 |
| 12/04/2004 | 77,78 | 80,44 | 77,78 | 79,43 | +1,97% | 3,42% | 135.106 |
| 08/04/2004 | 80,51 | 81,30 | 77,11 | 77,89 | -2,30% | 5,21% | 186.055 |
| 07/04/2004 | 79,43 | 80,10 | 77,89 | 79,73 | +0,33% | 2,78% | 265.564 |
| 06/04/2004 | 80,92 | 81,22 | 79,13 | 79,46 | -2,44% | 2,59% | 304.116 |
| 05/04/2004 | 79,69 | 82,35 | 79,28 | 81,45 | +2,93% | 3,85% | 609.781 |
| 02/04/2004 | 77,07 | 80,10 | 76,99 | 79,13 | +3,68% | 4,03% | 450.042 |
| 01/04/2004 | 76,13 | 78,23 | 75,27 | 76,32 | +1,44% | 3,88% | 416.887 |
| 31/03/2004 | 77,93 | 78,23 | 72,24 | 75,23 | -3,37% | 7,68% | 660.650 |
| 30/03/2004 | 76,32 | 78,38 | 74,37 | 77,85 | +1,17% | 5,25% | 414.776 |
| 29/03/2004 | 74,86 | 78,04 | 72,39 | 76,96 | +7,31% | 7,55% | 1.110.238 |
| 26/03/2004 | 70,89 | 73,36 | 70,44 | 71,72 | +0,84% | 4,12% | 402.674 |
| 25/03/2004 | 69,25 | 72,58 | 68,42 | 71,12 | +4,91% | 6,00% | 585.042 |
| 24/03/2004 | 67,19 | 68,57 | 65,84 | 67,79 | +1,12% | 4,07% | 348.145 |
| 23/03/2004 | 67,82 | 70,11 | 64,57 | 67,04 | -0,83% | 8,17% | 381.835 |
| 22/03/2004 | 70,37 | 70,56 | 66,92 | 67,60 | -4,14% | 5,16% | 321.882 |
| 19/03/2004 | 69,47 | 71,79 | 67,97 | 70,52 | +2,00% | 5,50% | 400.643 |
| 18/03/2004 | 68,65 | 69,99 | 67,94 | 69,13 | -1,23% | 3,00% | 235.187 |
| 17/03/2004 | 66,63 | 70,14 | 66,48 | 69,99 | +5,65% | 5,51% | 522.444 |
| 16/03/2004 | 64,60 | 67,34 | 64,60 | 66,25 | +3,51% | 4,23% | 387.632 |
| 15/03/2004 | 66,29 | 67,56 | 63,63 | 64,01 | -3,88% | 5,93% | 352.420 |